GleamWall
中文EN

ICCM IceCure Medical Ltd. Annual reports only

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1584371 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY2.7%
TTM net income YoY1.7%
TTM EPS YoY-20.0%
Revenue 3-yr CAGR3.1%
Net income 3-yr CAGR—

Margins

Gross margin36.3%
Operating margin-446.7%
Net margin-445.6%
FCF margin-432.4%
EBITDA margin-438.0%

Returns

ROE-188.8%
ROA-113.8%
ROIC (approx.)—
Asset turnover0.26x

Leverage & solvency

Liabilities / assets34.8%
Debt / equity0.00x
Current ratio2.61x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.97x
Accruals ratio-3.7%
Payout ratio—
Capex / revenue1.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$3.38M$3.29M
Cost of revenue$2.15M$1.84M
Gross profit$1.23M$1.45M
R&D expense$7.43M$7.10M
SG&A expense$4.53M$3.75M
Operating income-$15.09M-$15.70M
Net income-$15.06M-$15.32M
EBITDA-$14.80M-$15.36M
EPS (basic)0.240.30
EPS (diluted)0.240.30
Weighted avg. shares (diluted)63.58M50.88M
Balance sheet
Cash & equivalents$8.90M$7.56M
Receivables$331,000$221,000
Inventory$2.62M$1.99M
Current assets$12.61M$10.75M
PP&E, net$993,000$1.25M
Total assets$13.89M$12.58M
Current liabilities$4.82M$5.51M
Long-term debt$13,000$161,000
Total debt$13,000$161,000
Total liabilities$4.84M$5.67M
Shareholders' equity$9.05M$6.90M
Net debt-$8.88M-$7.40M
Shares outstanding73.12M56.57M
Cash flow statement
Operating cash flow-$14.57M-$12.56M
Capital expenditure$36,000$71,000
Free cash flow-$14.61M-$12.63M
Investing cash flow-$36,000$446,000
Financing cash flow$15.83M$9.19M
Depreciation & amortization$295,000$332,000
Stock-based compensation$1.37M$869,000

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.